Wei Rui
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 5
- CAR-T cell therapy research 5
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 2
- IL-33, ST2, and ILC Pathways 1
- Co-authors
- Xin Lin (6 shared papers)Xueqiang Zhao (5 shared papers)Guangna Liu (4 shared papers)Daosheng Huang (3 shared papers)Hongli Zheng (2 shared papers)Fei Yu (1 shared paper)Yuewei Zhang (1 shared paper)Jiahong Dong (1 shared paper)
- Journals
- Science Translational Medicine (1 paper)Cellular and Molecular Immunology (1 paper)Neuroscience (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Wei Rui
8 papers receiving 746 citations
Peers
Comparison fields: 5 of 63
- Oncology 433
- Immunology 223
- Genetics 97
- Cancer Research 114
- Developmental Neuroscience 19
Countries citing papers authored by Wei Rui
This map shows the geographic impact of Wei Rui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Rui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Rui more than expected).
Fields of papers citing papers by Wei Rui
This network shows the impact of papers produced by Wei Rui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Rui. The network helps show where Wei Rui may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Rui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 161 | |
| 2 | 2020 | 158 | |
| 3 | 2013 | 115 | |
| 4 | 2021 | 113 | |
| 5 | 2018 | 111 | |
| 6 | 2018 | 58 | |
| 7 | 2022 | 27 | |
| 8 | 2024 | 11 |
About Wei Rui
Wei Rui is a scholar working on Oncology, Immunology, Molecular Biology, Biomedical Engineering and Genetics, having authored 8 papers that have together received 754 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (3 papers), Nanowire Synthesis and Applications (2 papers), Immunotherapy and Immune Responses (2 papers), Mesenchymal stem cell research (1 paper), IL-33, ST2, and ILC Pathways (1 paper), Amyotrophic Lateral Sclerosis Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Oncology (433 citations), Immunology (223 citations), Genetics (97 citations), Cancer Research (114 citations) and Developmental Neuroscience (19 citations). Wei Rui has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xin Lin, Xueqiang Zhao, Guangna Liu, Daosheng Huang, Hongli Zheng, Fei Yu, Yuewei Zhang, Jiahong Dong, Lemei Jia and Yue Liu. Their work appears in journals such as Science Translational Medicine, Cellular and Molecular Immunology, Neuroscience, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.